A routine, well-planned CFO succession with a strong internal candidate returning to Amgen. The Dittrich appointment is a net positive given his prior Amgen tenure and IPO experience at Galderma, but the event is too small relative to Amgen's $175B market cap to drive a stock reaction. No trading action warranted — monitor Q2 earnings and any guidance changes for the real catalyst.
Price Chart
Executive Summary
Amgen CFO Peter Griffith is retiring effective August 31, 2026, with a transition period through January 2027. Thomas Dittrich, a former Amgen finance executive most recently CFO of Galderma, will return as Executive Vice President on July 1, 2026 and become CFO on September 1, 2026. This is a planned CEO succession at the CFO level with a named successor who has deep industry experience and prior Amgen tenure — a routine C-suite transition that carries no material financial impact.
Key Facts
- Peter Griffith to retire as EVP and CFO effective August 31, 2026
- Griffith remains as EVP (non-officer) from Sept 1, 2026 to Jan 31, 2027 for transition
- Thomas Dittrich appointed EVP (non-officer) July 1, 2026, becoming CFO Sept 1, 2026
- Dittrich was previously at Amgen (2006-2014) as VP Finance and CAO
- Dittrich most recently served as CFO of Galderma Group AG since October 2019
- Dittrich receives base salary of CHF 1,070,000, annual LTI target of CHF 4,500,000
- One-time make-whole RSU award of CHF 4,700,000 and cash bonus of CHF 4,000,000
- Two-year retention bonus of CHF 5,800,000 with clawback provisions
- Relocation allowance of CHF 250,000 for move from Switzerland to California
Financial Impact
No material financial impact. CFO transition costs are standard for a $175B company — total make-whole and retention compensation package of approximately CHF 14.5M plus relocation. No impact on revenue, earnings, or operations.
Risk Factors
- CFO transition risk — Dittrich starts July 1 but does not become CFO until September 1, creating a 2-month gap with Griffith in non-officer role
- Dittrich's multi-year make-whole awards (CHF 14.5M total) represent a sunk cost with no direct shareholder return
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000318154-26-000097 |
| Document: amgn-ex10_2.htm | 0000318154-26-000097 |
| Document: amgn-20260519.htm | 0000318154-26-000097 |
| Document: amgn-ex99_1.htm | 0000318154-26-000097 |
| Document: 0000318154-26-000097-index-headers.html | 0000318154-26-000097 |
| Document: 0000318154-26-000097-index.html | 0000318154-26-000097 |
| Document: 0000318154-26-000097.txt | 0000318154-26-000097 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | ANALYST-DOWNGRADE | $382.47 $379.78 | ▲ +0.70% | ▲ +0.20% | $403.04 (−5.38%) |
Sep 8, 2026 24d ago | ANALYST-DOWNGRADE | $393.17 $375.65 | ▲ +4.46% | ▲ +3.34% | $403.04 (−2.51%) |
Aug 14, 2026 7w ago | Court Ruling | $415.21 $439.33 | ▲ +5.81% | ▲ +7.18% | $403.04 (−2.93%) |
Aug 13, 2026 7w ago | Insider Cluster | $415.21 $439.33 | ▲ +5.81% | ▲ +7.18% | $403.04 (−2.93%) |
Aug 11, 2026 7w ago | Court Ruling | $414.30 $425.28 | ▲ +2.65% | ▲ +3.05% | $403.04 (−2.72%) |
Aug 7, 2026 7w ago | Insider Cluster | $417.20 $419.38 | ▲ +0.52% | ▲ +0.57% | $403.04 (−3.39%) |
Aug 7, 2026 7w ago | Insider Cluster | $417.20 $419.38 | ▲ +0.52% | ▲ +0.57% | $403.04 (−3.39%) |
Aug 7, 2026 7w ago | Insider Cluster | $417.20 $419.38 | ▲ +0.52% | ▲ +0.57% | $403.04 (−3.39%) |
Aug 4, 2026 8w ago | GOVT-CONTRACT | $390.02 $414.30 | ▲ +6.23% | ▲ +6.33% | $403.04 (+3.34%) |
Jul 31, 2026 9w ago | 8-K | $378.87 $417.20 | ▼ −10.12% | ▼ −8.09% | $403.04 (−6.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access